School of Chemical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Australian Centre for NanoMedicine (ACN), University of New South Wales, Sydney, NSW, 2052, Australia.
Adv Sci (Weinh). 2023 Mar;10(9):e2206546. doi: 10.1002/advs.202206546. Epub 2023 Jan 25.
Antibody-nanoparticle conjugates are promising candidates for precision medicine. However, developing a controllable method for conjugating antibodies to nanoparticles without compromising the antibody activity represents a critical challenge. Here, a facile and generalizable film-coating method is presented using zeolitic imidazole framework-8 (ZIF-8) to immobilize antibodies on various nanoparticles in a favorable orientation for enhanced cell targeting. Different model and therapeutic antibodies (e.g., Herceptin) are assembled on nanoparticles via a biomineralized film-coating method and exhibited high antibody loading and targeting efficiencies. Importantly, the antibodies selectively bind to ZIF-8 via their Fc regions, which favorably exposes the functional Fab regions to the biological target, thus improving the cell targeting ability of antibody-coated nanoparticles. In combination, molecular dynamics simulations and experimental studies on antibody immobilization, orientation efficiency, and biofunctionality collectively demonstrate that this versatile site-specific antibody conjugation method provides effective control over antibody orientation and leads to improved cell targeting for a variety of nanoparticles.
抗体-纳米粒子缀合物是精准医学的有前途的候选物。然而,开发一种可控的方法将抗体缀合到纳米粒子上而不损害抗体活性是一个关键的挑战。在这里,提出了一种使用沸石咪唑骨架-8(ZIF-8)的简便且可推广的薄膜涂层方法,以将抗体固定在各种纳米粒子上,以实现增强的细胞靶向的有利取向。通过生物矿化薄膜涂层方法将不同的模型和治疗性抗体(例如赫赛汀)组装到纳米粒子上,并表现出高的抗体负载和靶向效率。重要的是,抗体通过其 Fc 区域选择性地与 ZIF-8 结合,这有利于将功能 Fab 区域暴露于生物靶标,从而提高抗体包被纳米粒子的细胞靶向能力。总之,抗体固定、取向效率和生物功能的分子动力学模拟和实验研究共同表明,这种多功能的特异性抗体缀合方法可有效地控制抗体的取向,并提高各种纳米粒子的细胞靶向性。
J Mater Chem B. 2025-6-18
Nat Commun. 2025-5-23
J Nanobiotechnology. 2025-5-22
Nanomaterials (Basel). 2025-2-10
Mol Cancer. 2025-1-24
Int J Nanomedicine. 2024
Biomater Sci. 2020-8-7